April 29th, 2015 | The Motley Fool by Beth McKenna
Philadelphia-based start-up BioBots is aiming to shake up the human tissue engineering — or “3D bioprinting” — space by making its desktop 3D bioprinters available for only $5,000 to scientists, engineers, and medical professionals who qualify for its beta testing program.
This low-cost product strategy aims at putting bioprinters into the hands of as many professionals in the biotech and medical fields as possible. It has the potential to unleash a wave of innovation in the biotech world, and possibly catapult this upstart into the bigger leagues.
BioBots: Aiming to democratize the bioprinting world
BioBots was founded by several recent graduates of the University of Pennsylvania. Among a field of 48 finalists, whittled down from more than 500 entrants, the upstart from “Rocky’s” hometown knocked out the competition for “Most Innovative” honors at Oracle Corp.‘s South by Southwest 2015 Accelerator venture competition last month. SXSW has a reputation as a breeding ground for innovative new ideas in the tech realm.